Arca
Skip to content
Tools
Tools

Cytrellis ellacor System with Micro-Coring Technology-Dermal Micro-Coring System System…

Recall Z-1648-2023, part of FDA recall event 92187. See Cytrellis Biosystems's company page.

Cytrellis Biosystems, Inc. started this Class II device recall on Apr 7, 2023 (voluntary: firm initiated); FDA lists it as completed.

  • Classification: Class II
  • Started: Apr 7, 2023
  • Status: Completed

Why It Was Recalled

Class II

Irregular core patterns could cause potential overlap of cores at the 8% setting, potentially leading to prolonged healing, irregularities in patient skin texture post-treatment, and/or scarring.

Record

Product
Cytrellis ellacor System with Micro-Coring Technology-Dermal Micro-Coring System System intended for the treatment of moderate and severe wrinkles in the mid and lower face. Model #: Gen 4
Quantity
89 units
Lots and codes
UDI-DI: B933ELCON010 All serial numbers
Distribution
Nationwide
Recalling firm
Cytrellis Biosystems, Inc., Woburn, MA, United States
How the firm notified
E-Mail
FDA classified
May 26, 2023

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.